The content on this site is intended for healthcare professionals only
Prof Faivre-Finn presents about the current state of the art radiation medicine at the Future Horizons in Lung Cancer meeting.
Consolidation durvalumab after cCRT shows decreased disease progression in LS-SCLC
Multiple Myeloma: evolving paradigm - Panel Discussion
TROP2 expression measured by QCS is a promising predictor of clinical outcomes in patients with mNSCLC
TARGIT trial in intraoperative radiotherapy
Choosing Wisely for young women with breast cancer: Radiotherapy
Intraoperative radiotherapy at Fortis Healthcare Hospital
Biomarkers, predictive and prognostic factors of resistance to immunotherapy
Research highlights in lung cancer
Uncommon genetic aberrations NTRK, RET, NRG
